Status:
COMPLETED
Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
Lead Sponsor:
Infectopharm Arzneimittel GmbH
Collaborating Sponsors:
J&P Medical Research Ltd.
Sandoz GmbH
Conditions:
Bacterial Infection
Eligibility:
All Genders
Brief Summary
This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection. Primary objective: • To assess clinical and microbiological efficacy of...
Detailed Description
Please note that InfectoPharm Arzneimittel und Consilium GmbH has taken over sponsor responsibilities for all German sites of this clinical trial with Jannuary 2016 from J\&P MEDICAL RESEARCH LTD.
Eligibility Criteria
Inclusion
- Patients with bacterial infection receiving FOM for clinical purposes will be included into the analysis.
Exclusion
- \-
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT01173575
Start Date
August 1 2010
End Date
December 1 2016
Last Update
July 2 2019
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Graz
Graz, Styria, Austria, 8035
2
University Hospital Tübingen
Tübingen, Baden-Wurttemberg, Germany, 72076
3
Augsburg Hospital
Augsburg, Bavaria, Germany, 86156
4
Kreisklinik Guenzburg Krumbach
Krumbach, Bavaria, Germany, 86381